Michelle Gray, Ph.D., an Alabama native, joined the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET) on September 1, 2008 as an Instructor of Neurology and Dixon Scholar in Neuroscience. Dr. Gray has strong ties to Alabama and the UAB community. She graduated from Alabama State University in Montgomery in 1997 with a B.S. in biology and received her Ph.D. from Ohio State University in Molecular, Cellular, and Developmental Biology in 2003. Dr. Gray also served as a postdoctoral fellow in the Semel Institute of Neuroscience and Behavior at the University of California, Los Angeles.
Dr. Gray's research interests in neurodegenerative disorders are focused on Huntington's disease, a rare and fatal genetic degenerative disorder.
Erik Roberson, M.D., Ph.D. is a member of the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET) and holds a secondary appointment in the Department of Neurobiology. Dr. Roberson joined UAB in August, 2008 as the Virginia B. Spencer Scholar in Neuroscience.
Dr. Roberson’s primary interest is age-related memory disorders and neurodegenerative disease.
David Standaert, M.D., Ph.D. is John N. Whitaker Professor and chair of the Department of Neurolgoy and the director of the UAB Center for Neurodegeneration and Experimental Therapeutics (CNET). He also is director of the Division of Movement Disorders.
Dr. Standaert's lab is interested in the pharmacology and neurochemistry of the basal ganglia and the mechanisms of Parkinson's disease and other conditions which produce abnormalities of movement.
Andrew West, Ph.D. joined the Department of Neurology in September of 2007 as an Assistant Professor and the John A. & Ruth R. Jurenko Research Scholar. Dr. West received his undergraduate degree from Alma College and his PhD in Molecular Neuroscience from the Mayo Clinic School of Medicine in Rochester, MN. He then went on to complete a Postdoctoral Fellowship at UCLA Neuropsychiatric Institute in Los Angeles in the laboratory of Nigel Maidment and a second postdoctoral fellowship in the laboratory of Ted Dawson at Johns Hopkins. Dr. West is a recipient of an NIH/NINDS Pathway to Independence (PI) Award K99/R00.
The West Lab focuses on discovering the biochemical and genetic basis of neurological disorders such as Parkinson’s disease and autism spectrum disorders.
Talene Yacoubian, M.D., Ph.D. joined the department of Neurology in July of 2006, and is currently an Assistant Professor. Dr Yacoubian received her undergraduate degree from Harvard University, and her MD/PhD from Duke University in 2001. She completed a one year internship at Brigham & Women’s Hospital, Boston and a 3 year Residency in neurology at Massachusetts General Hospital/Brigham & Women’s Hospital. She finished a two year Fellowship in Movement Disorders in July of 2007. Dr. Yacoubian is a 2007 recipient of the American Parkinson Disease Association’s George C. Cotzias, MD Memorial Fellowship.
The Yacoubian Lab is focused on understanding the pathophysiology of Parkinson’s disease with the long-term goal of developing neuroprotective therapies.